Mid-America Transplant and MediGO team up to improve organ
ST. LOUIS, August 03, 2021 (GLOBE NEWSWIRE) – Mid-America Transplant is pleased to announce a partnership with MediGO, an innovative logistics and communications company dedicated to improving the transport of organs for transplantation. Using MediGO technology, Mid-America’s transplant and transplant surgeons will be able to closely monitor the location of organs during transit.
Mid-America Transplant plans to take a milestone in 2021 when it takes care of its 2,500th donor at its on-site recovery center. By donating organs at this world’s first such facility, Mid-America Transplant has greater control over the quality and efficiency of the transplant process. By partnering with MediGO, Mid-America Transplant addresses the challenges of urgently transporting organs to surgeons, whether on the road or across the country.
âTime is running out in organ donation. We often only have a few hours between when the donation is made and when the organ needs to be transplanted, and that can mean traveling hundreds of kilometers to reach the recipient, âsaid Dr Jason Wellen, transplant surgeon at Barnes Jewish Hospital in St. Louis. âWith MediGO’s technology, all of us will be able to see where the organ is located and its condition in real time, so that we can be fully prepared from the moment it arrives at our hospital. “
The MediGO platform uses a proprietary and innovative algorithm to predict and deliver an accurate ETA. MediGO provides full travel visibility to stakeholders along the entire transplant continuum, from the organ procurement organization (OPO) that facilitated organ donation to the surgical team waiting to receive it. All stakeholders are informed in real time of changes to ETA, in order to better manage resources and improve the chances of organ transplantation. These parties are informed of flight delays or diversions due to weather conditions, so that they can adapt as needed to give the organ the best chance of success. There is an urgent opportunity to apply innovations in medical technology to improve access to transplantable organs. While about 110,000 people are on the national organ waiting list, hundreds of thousands more Americans would benefit from greater access to transplant care. This fits with MediGO’s mission to improve clinical outcomes by increasing access to vital organs through efficient management of resources.
âWe are delighted to partner with Mid-America Transplant, which is considered a leader in the organ procurement industry with a history of innovation,â said Dr. Joseph Scalea, Co-Founder and Medical Director by MediGO. âOur vision has been to revolutionize the organ transplant community by tracking every piece of data along an organ’s vital journey, which is why we worked closely with OPOs to design a solution that saves time, money and improves the quality of the Gift of life. “
Previously, approximately 20% of Mid-America Transplant’s organs traveled outside of its service territory. Today, that number is closer to 70%, largely due to regulatory changes regarding how kidneys and livers are allocated nationally. As more and more organs travel further afield, the level of control and transparency provided by MediGO throughout the transport process will be more critical than ever.
âIt is our responsibility to the best possible stewards of the gifts donors and their families provide,â said Diane Brockmeier, President and CEO of MidAmerica Transplant. âAmazing innovations, like the MediGO platform, give organs the best possible chance of being successfully placed, so that the legacy of their loved one can live on in another.
About JSP Ventures
JSP Ventures starts up and invests in businesses that generate âtriple bottom lineâ ROIs measured by economic, social and environmental benefits that empower communities. We work with entrepreneurs and teammates who share our values ââof listening, service and activism. We execute our mission by providing leadership, funding, mentorship, infrastructure and our network. For more information, please visit www.jspventures.com.
MediGO is a cutting-edge logistics platform that enables real-time management of urgent medical consignments over a centralized communication channel. With new supply chain transparency, healthcare teams can be proactive in unifying stakeholders, coordinating resources, and making vital decisions to deliver care at the pace of life. MediGO is a holding company within JSP Ventures. Visit gomedigo.io to learn more.
About Mid-America Transplant
Mid-America Transplant enables adults and children to receive vital gifts through organ and tissue donation. For more than 40 years, he has facilitated and coordinated organ, tissue and eye donation, and now serves 84 counties spanning eastern Missouri, southern Illinois and northeast Arkansas. which together are home to 4.7 million people. It saves lives by providing expert and compassionate care to organ donors, recipients and families, and transforms the clinical processes required to recover and transplant organs and tissues. Mid-America Transplant was the first such organization in the United States to use an internal operating room for organ harvesting and pioneered innovative models to increase donor registry registrations with the goal of providing organs and tissues to those who need them. It is designated by the federal government as one of 58 such organizations in the United States and is the first organ procurement organization to be recognized as a recipient of the Malcolm Baldrige National Quality Award for Performance Excellence. For more information visit www.midamericatransplant.org.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/29d1e888-b979-4b44-a467-cf85a70fddea